NO952907L
Transdermal therapeutic system with galanthamine as active ingredient.
Abstract
PCT No. PCT/EP94/00054 Sec. 371 Date Sep. 29, 1995 Sec. 102(e) Date Sep. 29, 1995 PCT Filed Jan. 10, 1994 PCT Pub. No. WO94/16707 PCT Pub. Date Aug. 4, 1994A transdermal therapeutic system (TTS) for the administration of galanthamine to the skin each system having a backing layer which is impermeable to active substances and a pressure sensitive adhesive reservoir layer, wherein the reservoir layer comprises 40-80% wt. polymeric material selected from the group consisting of polyacrylates, 0.1-30%-wt. plasticizers, and 0.1-30%-wt. galanthamine base or one of its pharmaceutically acceptable salts.
Term
No projected expiry on record.
- Priority
- Filed and published
- Today
43 members in 26 offices
Priority claims8
| Document | Office | Kind | Date |
|---|---|---|---|
| 4301783 | Germany | A | |
| 4301783 | Germany | A | |
| 9400054 | European Patent Office (EPO) | W | |
| 9400054 | European Patent Office (EPO) | W | |
| 4301783 | – | – | – |
| DE19934301783 | – | – | – |
| EP9400054 | – | – | – |
| WO1994EP00054 | – | – | – |
Members43
| Document | Office | Kind | |
|---|---|---|---|
| DE4301783C1 | Germany | C1 | |
| IL108235D0 | Israel | D0 | |
| CA2153572A1 | Canada | A1 | |
| WO9416707A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU5881794A | Australia | A | |
| ZA94414B | South Africa | B | |
| SI9400024A | Slovenia | A | |
| FI953533A | Finland | A | |
| NO952907D0 | Norway | D0 | |
| NO952907LThis record | Norway | L | |
| HU9501928D0 | Hungary | D0 | |
| PL309603A1 | Poland | A1 | |
| EP0680325A1 | European Patent Office (EPO) | A1 | |
| CZ184295A3 | Czechia | A3 | |
| KR960700060A | Republic of Korea | A | |
| NZ259857A | New Zealand | A | |
| SK88995A3 | Slovakia | A3 | |
| HUT72643A | Hungary | A | |
| JPH08505632A | Japan | A | |
| HRP940028A2 | Croatia | A2 | |
| YU2694A | Yugoslavia, later Serbia and Montenegro (until 2006) | A | |
| IL108235A | Israel | A | |
| AU679032B2 | Australia | B2 | |
| MY109926A | Malaysia | A | |
| US5700480A | United States of America | A | |
| PL175083B1 | Poland | B1 | |
| PH31473A | Philippines | A | |
| YU48607B | Yugoslavia, later Serbia and Montenegro (until 2006) | B | |
| HRP940028B1 | Croatia | B1 | |
| NO307497B1 | Norway | B1 | |
| CZ287053B6 | Czechia | B6 | |
| SK281339B6 | Slovakia | B6 | |
| KR100300477B1 | Republic of Korea | B1 | |
| EP0680325B1 | European Patent Office (EPO) | B1 | |
| AT216240T | Austria | T | |
| ATE216240T1 | Austria | T1 | |
| DE59410103D1 | Germany | D1 | |
| DK0680325T3 | Denmark | T3 | |
| HU221165B1 | Hungary | B1 | |
| PT680325E | Portugal | E | |
| ES2176234T3 | Spain | T3 | |
| FI113744B | Finland | B | |
| CA2153572C | Canada | C |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Lapsed by not paying the annual feesLapsedMM1K | MM1K |
Numbers
- Publication, DOCDB
- 952907
- Publication, EPODOC
- NO952907L
- Application
- 952907
- Application, DOCDB
- 952907
- Application, EPODOC
- NO19950002907
Titles2
- Norwegian
- Transdermalt terapeutisk system med galanthamin som virksom bestanddel
- English
- Transdermal therapeutic system with galanthamine as active ingredient
Classification
- CPC, 6
- A61K9/7061
- A61K31/55
- A61P25/28
- A61P27/12
- A61P37/02
- A61K9/70
- IPC, 4
- A61K9 70
- A61K31 55
- A61L15 00
- A61M37 00